Dietary Supplements
Methodology & AI Transparency ⓘ
Dietary Supplements Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Dietary supplements are vitamins , minerals , herbs , and many other products.
- 2 Real-world patient consensus: Mapped to Osteoporosis, Vitamin D & Bone Density under ICD-10-CM M80.2 for Dietary Supplements clinical workups.
- 3 Typical cash cost range: Differential triage of Dietary Supplements (M80.2) utilizes calcium + vitamin in Dietary Supplements (M80.2: D3/K2 sufficiency).
- 4 Top reported side effects / signs: Longitudinal Dietary Supplements monitoring tracks Serum Calcium, Phosphorus in Dietary Supplements (M80.2: & PTH) toward Ca 8.9–10.1 mg/dL; PTH 15–65 pg/mL (M80.2).
Ask our AI Specialists anything about Dietary Supplements
What Is Dietary Supplements?
Dietary supplements are vitamins , minerals , herbs , and many other products. They can come as pills, capsules, powders, drinks, and energy bars. Supplements do not have to go through the testing that drugs do. Some supplements can play an important role in health. For example, calcium and vitamin D are important for keeping bones strong. Pregnant women can take the vitamin folic acid to prevent certain birth defects in their babies.
Pathophysiology, Underlying Causes & Clinical Presentation
In Dietary Supplements (M80.2), physiological disruption stems from uncoupled skeletal remodeling in Dietary Supplements (M80.2: where osteoclast-mediated bone), Cross-referenced with NIH MeSH (Dietary Supplements), informing Osteoporosis, Vitamin D & Bone Density protocols that track CTX / P1NP in Dietary Supplements (M80.2: Bone Turnover Markers) (Balanced remodeling on therapy (M80.2)).
Common Symptoms & Clinical Signs
- • Tell your health care provider about any dietary supplements you use
- • Do not take a bigger dose than the label recommends
- • Presentation of Dietary Supplements (M80.2): gradual loss of in Dietary Supplements (M80.2: standing height)
- • Secondary Dietary Supplements clinical sign: diffuse bone aching in Dietary Supplements (M80.2: or muscle weakness)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Dietary Supplements Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | M80.2 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Osteoporosis, Vitamin D & Bone Density | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Serum Calcium, Phosphorus in Dietary Supplements (M80.2: & PTH) | Ca 8.9–10.1 mg/dL; PTH 15–65 pg/mL (M80.2) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: CTX / P1NP in Dietary Supplements (M80.2: Bone Turnover Markers) | Balanced remodeling on therapy (M80.2) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: DEXA Bone Mineral in Dietary Supplements (M80.2: Density T-Score) | > -1.0 (hip & lumbar spine) (M80.2) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Dietary Supplements
Treatment selection for Dietary Supplements depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Dietary Supplements)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Testosterone supplementation and bone: What a 3,103-Participant Study Found TRT is able to inhibit bone resorption and increase bone mass, particularly at the lumbar spine level and when the duration is long enough to allow the anabolic effect of T and estrogens on bone metabolism to take place. Journal of endocrinological investigation • 2022-05-15 • Meta-Analysis | N = 3,103 | 99/100 | PMID 35041193 ↗ |
| New Insights on Early maternal DHA supplementation fails to modify clinical phenotypes associated: What a 404-Participant Study Found Daily DHA supplementation (600 mg) from early pregnancy was safe and well tolerated but did not demonstrate a statistically significant effect on clinical phenotypes of impaired placentation. Placenta • 2026-05-22 • Phase III Randomized Trial | N = 404 | 93/100 | PMID 42025271 ↗ |
| New Insights on A Protective Role for Arachidonic Acid Metabolites against Advanced Colorectal: What a 256-Participant Study Found Selenium supplementation was associated with a significantly smaller increase in 5-HETE after 12 months compared to the placebo, though no other results were statistically significant. Nutrients • 2021-10-29 • Phase III Randomized Trial | N = 256 | 93/100 | PMID 34836131 ↗ |
| New Insights on Magnesium and potassium supplementation on trouble sleeping and sleep hormones in: What a 320-Participant Study Found The study revealed that magnesium, potassium, and magnesium and potassium combined had a significant effect on serum cortisol and melatonin levels (sleep hormones). Frontiers in endocrinology • 2024-01-15 • Randomized Controlled Trial | N = 320 | 93/100 | PMID 39534260 ↗ |
| New Insights on Benefits and safety of Weekly Calcifediol Formulations (75 and 100 µg) in: What a 376-Participant Study Found New weekly calcifediol 75 and 100 µg formulations showed an effective and sustained response with a good long-term safety profile. Nutrients • 2024-11-05 • Phase III Randomized Trial | N = 376 | 93/100 | PMID 39599585 ↗ |
Dietary Supplements Patient Community & “People Like Me” Threads
Filter Dietary Supplements community threads and patient logs by age, biological sex, dosage, and treatment duration.